loader image
Saturday, January 17, 2026
63.7 F
McAllen
- Advertisement -

Clot-Busting Drug May Be Safe for People with Stroke and Unruptured Aneurysms

Translate to Spanish or other 102 languages!

Clot-busting drugs are the main treatment for stroke, but they have often not been recommended for people who have an aneurysm in their brains that has not ruptured. Image for illustration purposes.

Mega Doctor News

- Advertisement -

By American Academy of Neurology (AAN)

Newswise — MINNEAPOLIS – Clot-busting drugs are the main treatment for stroke, but they have often not been recommended for people who have an aneurysm in their brains that has not ruptured. An aneurysm is a bulge in the wall of a blood vessel in the brain. A new study finds that these aneurysms rarely burst after treatment with clot-busting drugs, so the drugs may be safe for use. The study is published in the October 6, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology.

“These results are exciting because they may expand the population who can receive these thrombolytic therapies that can prevent death and disability for people with strokes,” said study author Jyri Juhani Virta, MD, PhD, of the University of Helsinki in Finland.

- Advertisement -

For the study, researchers looked at the records for all people with a stroke who were treated with clot-busting drugs at a stroke center in Finland over 15 years. After determining how many had unruptured aneurysms, they then looked to see how many people had a hemorrhagic stroke, or an intracranial hemorrhage, caused by the rupture of the aneurysm while they were in the hospital after the treatment.

Of the 3,953 people in the study, 132 people had one or more unruptured aneurysms. Of the 155 unruptured aneurysms, 141 were the type called saccular aneurysms and 14 were fusiform aneurysms.

The aneurysms ruptured after treatment causing a hemorrhagic stroke in only three people, or 2.3%. All three had large aneurysms called fusiform basilar artery aneurysms. All three were treated with blood thinners after their treatment. None of the saccular type of aneurysms ruptured.

“Fortunately, today blood thinners are not commonly used early after ischemic stroke, so that may help to reduce this risk even further,” Virta said. “Our results suggest that thrombolytic therapy may be relatively safe for people with ischemic stroke even if they have larger saccular aneurysms that have not ruptured. For people with large fusiform aneurysms, additional consideration should be taken regarding treatment as blood thinners may increase the risk of aneurysm rupture.”

- Advertisement -

 A limitation of the study was that only a small number of people had large aneurysms.

Learn more about stroke at BrainandLife.org, home of the American Academy of Neurology’s free patient and caregiver magazine focused on the intersection of neurologic disease and brain health. Follow Brain & Life® on Facebook, Twitter and Instagram. #Neurology and #AANscience.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Backs Education at 30th Annual VAMOS Golf Tournament

The Valley Alliance of Mentors for Opportunities and Scholarships (VAMOS) will hold a press conference on Wednesday, January 28, 2026, at 10:00 a.m. at the Edinburg Conference Center at Renaissance, located at 118 Paseo Del Prado, Edinburg, TX 78539,  to announce DHR Health as the Presenting Sponsor of the 30th Annual VAMOS Golf Tournament, scheduled for Saturday, March 7, 2026 at Champion Lakes Golf Course in McAllen, Texas. This is the organization’s largest fundraiser and one of the most anticipated charitable sporting events in the region.

Abbott Directs State Agencies to Probe Possible Medicaid Fraud

Governor Greg Abbott sent a letter directing the Texas Health and Human Services (HHS) Office of Inspector General and the Texas Health and Human Services Commission (HHSC) to launch investigations into potential Medicaid fraud in Texas to safeguard taxpayer funds, maintain access for eligible Texans, and ensure efficient, high-quality healthcare delivery.

STHS McAllen Opens $12 Million Neuro ICU

Frequently complex in nature, brain and spinal cord injuries and illnesses require specialized care for a patient’s successful recovery.

Scientists Identify a Treatable Vulnerability in Aggressive Blood Cancer

New research co-led by Indiana University School of Medicine scientists has exposed a vulnerability in acute myeloid leukemia by identifying the blood cancer's reliance on a specific signaling pathway involved in the body's inflammation response.
- Advertisement -
×